MILLENNIUM MANAGEMENT LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 71 filers reported holding RECRO PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$6,274
-87.9%
13,378
-71.6%
0.00%
Q2 2023$51,896
+83603.2%
47,178
-9.7%
0.00%
Q1 2023$62
+287.5%
52,226
+380.2%
0.00%
Q4 2022$16
-100.0%
10,876
-57.9%
0.00%
Q3 2022$42,000
-33.3%
25,853
-26.6%
0.00%
Q1 2022$63,000
+8.6%
35,203
+3.1%
0.00%
Q4 2021$58,000
-19.4%
34,155
-2.4%
0.00%
Q3 2021$72,000
-75.5%
34,985
-72.5%
0.00%
Q2 2021$294,000
+3.2%
127,382
+103.3%
0.00%
Q2 2020$285,000
-99.9%
62,644
-88.6%
0.00%
-100.0%
Q4 2019$453,196,000
+35697.5%
547,143
+378.6%
0.57%
+28250.0%
Q3 2019$1,266,000
-10.0%
114,312
-17.4%
0.00%0.0%
Q2 2019$1,407,000
+205.2%
138,377
+112.9%
0.00%
+100.0%
Q4 2018$461,000
-27.1%
64,983
-26.9%
0.00%0.0%
Q3 2018$632,000
-11.1%
88,929
-37.2%
0.00%0.0%
Q2 2018$711,000
-76.8%
141,710
-49.0%
0.00%
-75.0%
Q1 2018$3,060,000
+644.5%
277,892
+491.5%
0.00%
+300.0%
Q1 2017$411,000
+11.1%
46,981
+2.5%
0.00%0.0%
Q4 2016$370,000
+21.3%
45,853
+80.6%
0.00%0.0%
Q3 2015$305,00025,3910.00%
Other shareholders
RECRO PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders